<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

3 min read

SmartTRAK Publication Alert: US Spinal Cord Stimulation Market Recap

6/25/18 11:32 PM

SmartTRAK Alert Blog Post Social Media - Q118 SCS RecapSmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 US Spinal Cord Stimulation Market Recap.

The US Spinal Cord Stimulation (SCS) market saw another quarter of exceptional growth in Q118, yet the market decelerated QoQ, posting 23% growth vs 24.6% growth in Q417. While seasonal trends were behind the QoQ slowdown ...

Among the many topics covered in the full Q118 SCS Market Recap are: 

  • Market Overview
  • Across the Board Double-Digit Growth
  • Abbott Still No. 1
  • Boston Scientific Posts Solid Growth
  • Medtronic Gaining Ground
  • Nevro: Mixed Results in Q118
  • Selected Regulatory and Clinical Highlights in Q118

Read entire Market Recap including news, data and analysis*...

*This article can only be viewed by SmartTRAK subscribers to this module. For information on how to subscribe, please click the button below.

Request SmartTRAK Subscription Info

Topics: Neuro Therapies

Anne Staylor
Written by Anne Staylor

Former Senior Editor, Medtech Insight. +25 years in various leadership roles in business intelligence, marketing, communications, product management, and consulting for medical device industry, hospitals, physician groups, insurers. Registered nurse and former Director of Marketing for a national ambulatory surgery company.

  • There are no suggestions because the search field is empty.

Follow Us on Social Media

Recent Articles